Rein Therapeutics Net Debt Growth & History (RNTX)

Rein Therapeutics's net debt was −$12.9M for fiscal 2024.

View full Rein Therapeutics company overview

Rein Therapeutics annual net debt history

Rein Therapeutics annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20242024-12-31−$12.9M$4.4M
20232023-12-31−$17.3M−$12.1M
20222022-12-31−$5.1M−$1.7M
20212021-12-31−$3.4M
20192019-12-31−$278,000$5.0M
20182018-12-31−$5.2M

Rein Therapeutics net debt trends

Over the last five fiscal years, Rein Therapeutics's net debt decreased from −$278,000 to −$12.9M, a change of −$12.6M. The latest reported quarter, Q1 2026, shows $478,000.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Rein Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about RNTX yet. Start the conversation.

Write the first post